IceCure reports ‘very promising’ early results in large US clinical trial, plans to present results by mid-2021
The Israeli med-tech company IceCure Medical has reported “very promising” early results in clinical trials of its innovative breast cancer treatment, which relies on a liquid nitrogen technology to freeze tumors and destroy abnormal tissue.
Sign Up for Mideast Daily News
Wake up to the Trusted Mideast News source
By subscribing, you agree to The Media Line terms of use and privacy policy.
The firm is nearing completion of a major clinical trial in hospitals across the United States where it has already treated hundreds of women.